This seems plausible. German gov have said they don’t want to approve for over 65s due to the small sample size of 8%, which is reasonable.
Our own clinical advice says that conclusions on efficacy can’t be drawn in the over 65 cohort due to small sample size, but we approved as there is some evidence of immuno response.
Tabloid journalist totally misunderstands, and prints.
If that's the case then that's a very real issue. An issue The Lancet and US authorities have picked uo on. And it's the reason that no western nation has ok'd this vaccine for the older age groups.
The Oxford vaccine were told that this was a glaring problem. They then announced more testing on that and went away early in December and remained silent. Then we had reports right at the end of that month from leaked reports that they were now happy with the efficacy of their vaccine and the UK regulators were minded to hand them an emergency license.
It seems to be as clear as day what's happened here: no substantive attempt has been made by Oxford/AZ to test the rigour of their earlier data on efficacy of their vaccine for older groups and they merely came back with another sales pitch - pushed hard by a UK government that hadn't secured the number of Pfizer vaccines they promised and who wanted their own catastrophic failures on keeping infections under control buried under a good news story of handing more vaccines out than anywhere else per capita...regardless of the ability of one of those vaccines to protect the most vulnerable.
If the EU knock this AZ vaccine back for over-65s this week then we are into an utter excrement storm here in this country. And it wont do for this government and their lap dogs in the British media to push a "EU trying to nobble AZ over witheld deliveries of it" line. That's a line for the birds and the serfs.